Work

The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial

Year: 2004

Type: article

Source: The Pharmacogenomics Journal

DOI: 10.1038/sj.tpj.6500238

Authors: C Lerman, E P Wileyto, F Patterson, M Rukstalis, J Audrain-McGovern, S Restine, P G Shields, V Kaufmann, D Redden, N Benowitz, W H Berrettini

Institutions: Abramson Cancer Center, University of Pennsylvania, Georgetown University, Georgetown Lombardi Comprehensive Cancer Center, University of Alabama at Birmingham, University of California, San Francisco

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Public Health Service, National Institute on Drug Abuse, National Cancer Institute, National Center for Research Resources

Awards: G108849175, G3150410951, G3866081536, G4371882924, G5500714493, G6947962687

OpenAlex ID: W1966042288

FWCI: 12.34

Cites: 64

Cited by: 195

Related to: 10